Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
3.160
+0.030 (0.96%)
Apr 22, 2026, 10:25 AM EDT - Market open
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $351.78 million as of April 22, 2026. Its market cap has increased by 482.57% in one year.
Market Cap
351.78M
Enterprise Value
241.94M
1-Year Change
482.57%
Ranking
Category
Stock Price
$3.16
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $351.78M, an increase of 49.36%. That is a compound annual growth rate of 6.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 367.92M | 74.52% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ovid Therapeutics | 381.12M |
| X4 Pharmaceuticals | 380.95M |
| Puma Biotechnology | 374.96M |
| Nautilus Biotechnology | 374.63M |
| Silence Therapeutics | 374.57M |
| YD Bio | 373.40M |
| Prelude Therapeutics | 372.23M |
| Surrozen | 370.45M |